Sandoz Aktie
36,70CHF | -0,62CHF | -1,66% |
WKN DE: SANDOZ / ISIN: CH1243598427
Personal
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Personal am Ende des Jahres | 0 | 0 | 0 | 20 000 | 23 000 |
Umsatz pro Mitarbeiter in Mio. EUR | 0,00 | 0,00 | 0,00 | 0,45 | 0,40 |
Bilanz (in Mio. CHF) - Aktiva
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Summe Umlaufvermögen | 4 988 | 5 071 | 5 529 | 6 373 | 7 070 |
Summe Anlagevermögen | 10 875 | 10 913 | 10 715 | 9 980 | 10 971 |
Summe Aktiva | 15 863 | 15 983 | 16 244 | 16 353 | 18 041 |
Bilanz (in Mio. CHF) - Passiva
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Summe Fremdkapital | 9 037 | 8 546 | 8 139 | 9 070 | 10 642 |
Summe Eigenkapital | 6 827 | 7 438 | 8 105 | 7 284 | 7 399 |
Summe Passiva | 15 863 | 15 983 | 16 244 | 16 353 | 18 041 |
Adresse
Suurstoffi 14, 6343 Rotkreuz | |
Internet | http://www.sandoz.com |
Management
Aarti S. Shah
Independent Director |
Christophe Delenta
President-Europe |
Claire D'Abreu Hayling
Chief Scientific Officer |
Gilbert Ghostine
Chairman |
Glenn A. Gerecke
Chief Manufacturing & Supply Officer |
Graeme David Pitkethly
Independent Director |
Ingrid Sollerer
Chief Compliance Officer & Group General Counsel |
Ioannis Skoufalos
Independent Director |
Karen J. Hübscher
Vice Chairman |
Keren Haruvi
President-North American Region |
Kirsten Harting
Chief Medical Officer |
Maria Rosaria Varsellona
Independent Director |
Marta Vlatchkova
Chief Accounting Officer |
Mathai Mammen
Independent Director |
Michael Rechsteiner
Independent Director |
Peter Stenico
President-International Region |
Pierre Bourdage
Chief Commercial Officer |
Rebecca Guntern Flückiger
Chief Commercial Officer |
Remco J. Steenbergen
Chief Financial Officer |
Richard Saynor
Chief Executive Officer |
Shamiram R. Feinglass
Independent Director |
Tripti Jha
Chief People Officer |
Urs Riedener
Independent Director |